174 related articles for article (PubMed ID: 8394291)
1. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides.
Guis C; Bruetschy L; Meudal H; Roques BP; Gacel GA
Int J Pept Protein Res; 1993 Jun; 41(6):576-86. PubMed ID: 8394291
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptors.
Gacel GA; Fellion E; Baamonde A; Dauge V; Roques BP
Peptides; 1990; 11(5):983-8. PubMed ID: 1980943
[TBL] [Abstract][Full Text] [Related]
3. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
4. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
5. Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculations.
Belleney J; Gacel G; Fournié-Zaluski MC; Maigret B; Roques BP
Biochemistry; 1989 Sep; 28(18):7392-400. PubMed ID: 2554969
[TBL] [Abstract][Full Text] [Related]
6. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors.
Gacel G; Daugé V; Breuzé P; Delay-Goyet P; Roques BP
J Med Chem; 1988 Oct; 31(10):1891-7. PubMed ID: 2845081
[TBL] [Abstract][Full Text] [Related]
7. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF
Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736
[TBL] [Abstract][Full Text] [Related]
8. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
9. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
Lomize AL; Pogozheva ID; Mosberg HI
Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
[TBL] [Abstract][Full Text] [Related]
10. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
[TBL] [Abstract][Full Text] [Related]
12. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy.
Belleney J; Roques BP; Fournie-Zaluski MC
Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682
[TBL] [Abstract][Full Text] [Related]
13. The aspartic acid in deltorphin I and dermenkephalin promotes targeting to delta-opioid receptor independently of receptor binding.
Sagan S; Charpentier S; Delfour A; Amiche M; Nicolas P
Biochem Biophys Res Commun; 1992 Sep; 187(3):1203-10. PubMed ID: 1329732
[TBL] [Abstract][Full Text] [Related]
14. [3H]DSTBULET, a new linear hexapeptide with both an improved selectivity and a high affinity for delta-opioid receptors.
Delay-Goyet P; Seguin C; Daugé V; Calenco G; Morgat JL; Gacel G; Roques BP
NIDA Res Monogr; 1986; 75():197-200. PubMed ID: 2828972
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
[TBL] [Abstract][Full Text] [Related]
16. Topographical requirements for delta-selective opioid peptides.
Nikiforovich GV; Hruby VJ; Prakash O; Gehrig CA
Biopolymers; 1991 Jul; 31(8):941-55. PubMed ID: 1782355
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
18. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP
Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135
[TBL] [Abstract][Full Text] [Related]
19. [D-Ala2]deltorphin II analogs with high affinity and selectivity for delta-opioid receptor.
Sasaki Y; Ambo A; Suzuki K
Biochem Biophys Res Commun; 1991 Oct; 180(2):822-7. PubMed ID: 1659404
[TBL] [Abstract][Full Text] [Related]
20. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
